Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |